Jiyang Zhang

Jiyang Zhang

Auto-generated profile, based on publicly available information

Jiyang Zhang

Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University , Piscataway, NJ 08854

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2024 in Endocrinology
Verified
Journal Article
Closed access
PDF file
TZTingjie Zhan
Tingjie Zhan
JZJiyang Zhang
Jiyang Zhang
YZYing Zhang
Ying Zhang
QZQingshi Zhao
Qingshi Zhao
ACAnat Chemerinski
Anat Chemerinski
SXShuo Xiao
Shuo Xiao
Follicle-stimulating hormone (FSH) binds to its membrane receptor (FSHR) in granulosa cells to activate various signal transduction pathways and drive the gonadotropin-dependent phase of folliculogenesis. Poor female reproductive outcomes can result from both FSH insufficiency owing to genetic or non-genetic factors and FSH excess as encountered with ovarian stimulation in assisted reproductive technology (ART), but the underlying molecular mechanisms remain elusive. Herein, we conducted single-follicle and single-oocyte RNA sequencing analysis along with other approaches in an ex vivo mouse folliculogenesis and oogenesis system to investigate the effects of different concentrations of FSH on key follicular events. Our study revealed that a minimum FSH threshold is required for follicle maturation into the high estradiol-secreting preovulatory stage, and such threshold is moderately variable among individual follicles between 5-10 mIU/mL. FSH at 5, 10, 20, and 30 mIU/mL induced distinct expression patterns of follicle maturation-related genes, follicular transcriptomics, and follicular cAMP levels. RNA-seq analysis identified FSH-stimulated activation of G proteins and downstream canonical and novel signaling pathways that may critically regulate follicle maturation, including the cAMP/PKA/CREB, PI3K-AKT/FOXO1, and glycolysis pathways. High FSH at 20 and 30 mIU/mL resulted in non-canonical FSH responses including premature luteinization, high production of androgen and proinflammatory factors, and reduced expression of energy metabolism-related genes in oocytes. Together, this study improves our understanding of gonadotropin-dependent folliculogenesis and provides crucial insights into how high doses of FSH used in ART may impact follicular health, oocyte quality, pregnancy outcome, and systemic health.

12 September 2025 in Biology of Reproduction
Verified
Journal Article
Closed access
YSYunman (Sonia) Song
Yunman (Sonia) Song
JZJiyang Zhang
Jiyang Zhang
YBYingnan Bo
Yingnan Bo
QZQiang Zhang
Qiang Zhang
SKSo-Youn Kim
So-Youn Kim
SXShuo Xiao
Shuo Xiao
The remarkable advances in cancer therapies significantly enhance the survival rates and longevity of cancer patients. Among childhood, adolescent, and young adult female cancer survivors, however, anti-cancer agents frequently cause primary ovarian insufficiency, early menopause, and infertility, primarily due to the depletion of the ovarian reserve. Oocytes, the female germ cells, exhibit a notable susceptibility to DNA damage, given that they remain in meiotic arrest at prophase I for prolonged durations, from months to years, which increases the risks of accumulating DNA damage overtime. To counteract this, a tightly controlled DNA damage response signaling ensures that only oocytes with an intact genome progress to ovulation, fertilization, and next generations. Chemotherapeutic anti-cancer agents, including doxorubicin, cisplatin, cyclophosphamide, along with irradiation, elicit DNA damage via various mechanisms, including DNA crosslinking, single- and double-strand DNA breaks, and oxidative stress. The genotoxic insults activate DDR in the oocytes, which detect and repair DNA damage or initiate apoptosis to eliminate impaired oocytes. Although several protein molecules such as DNA damage-sensing kinases, checkpoint kinases, p53 family transcription factors, and pro-apoptotic molecules have been discovered, the precise mechanisms of DDR in determining the fate of oocytes, particularly how they differ from those in somatic cells and cancer cells, remain poorly understood. From an oncofertility perspective, the current review analyzes the molecular mechanisms of anti-cancer agent-induced DDR in oocytes and discusses knowledge gaps and urgent future research directions for preserving the ovarian reserve, fertility, and endocrine functions of young female cancer patients.

5 June 2026 in Biology of Reproduction
Verified
Journal Article
Closed access
SLShichao Liu
Shichao Liu
JZJiyang Zhang
Jiyang Zhang
TZTingjie Zhan
Tingjie Zhan
QZQiang Zhang
Qiang Zhang
NDNataki C Douglas
Nataki C Douglas
SXShuo Xiao
Shuo Xiao
Hormonal stimulation with estradiol and progesterone elicits broader and more physiologically relevant decidualization responses than cyclic adenosine monophosphate alone in 3D human endometrial organoids.

3 September 2026 in Biology of Reproduction
Verified
Journal Article
Closed access
MBMahdi Babaei
Mahdi Babaei
JZJiyang Zhang
Jiyang Zhang
SXShuo Xiao
Shuo Xiao
YGYu Gan
Yu Gan

1 October 2026 in Toxicological Sciences
Verified
Journal Article
Closed access
SCSamantha L Cheron
Samantha L Cheron
KOKunlin Ou
Kunlin Ou
TZTingjie Zhan
Tingjie Zhan
JZJiyang Zhang
Jiyang Zhang
CZCongcong Zhang
Congcong Zhang
SXShuo Xiao
Shuo Xiao
Humans are exposed to complex mixtures of endocrine-disrupting chemicals (EDCs) in the real world. Most prior studies, however, focus on individual EDCs. Here, we investigated the ovarian impact of organic pollutant mixtures extracted from the Raritan River, a heavily industrialized watershed in central New Jersey, using a three-dimensional (3D) in vitro ovarian follicle culture system. Ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) identified organic pollutant mixtures dominated by alkylphenols, pharmaceuticals, per- and polyfluoroalkyl substances (PFAS), and phthalates, together with previous reports demonstrating that the Raritan River also contains hydrophobic persistent organic pollutants (POPs), including polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and dioxins. In vitro exposure to the Raritan River-derived EDC mixture did not affect follicle growth and ovulation but dose-dependently increased preovulatory testosterone (T) secretion while suppressing postovulatory progesterone (P4) production. Transcriptomic analysis, gene set enrichment analysis (GSEA), reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and in situ RNA hybridization revealed widespread reprogramming of follicular somatic cell gene expression, including altered steroidogenic pathways and activation of aryl hydrocarbon receptor (AhR) signaling. An established AhR agonist, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), reproduced the phenotype of EDC mixture-induced hyperandrogenism, which was reversed by a selective AhR inhibitor. Together, this study demonstrates that real-world EDC mixtures, particularly AhR-activating chemicals, disrupt ovarian steroidogenesis and induce hyperandrogenism, highlighting EDC mixtures as an underrecognized mechanism potentially linking aquatic pollution to impaired women’s reproductive health.

30 October 2026 in Biology of Reproduction
Verified
Journal Article
Closed access
OCOlivia Chafitz
Olivia Chafitz
TNTova Niderberg
Tova Niderberg
SYShaojun Yang
Shaojun Yang
JZJiyang Zhang
Jiyang Zhang
SMSara S Morelli
Sara S Morelli
SXShuo Xiao
Shuo Xiao
Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), is the most common reproductive, endocrine, and metabolic disorder affecting 11-13% of adolescent girls and women of reproductive age. Although anovulation has traditionally been considered the primary cause of PMOS-associated infertility, accumulating evidence demonstrates that impaired endometrial receptivity and decidualization also contribute substantially to embryo implantation failure, recurrent pregnancy loss, and other adverse pregnancy outcomes, including miscarriage, gestational diabetes, pregnancy-induced hypertension, preeclampsia, and preterm birth. In addition to reproductive disorders, women with PMOS also commonly present with obesity, insulin resistance, and other long-term health conditions. This review summarizes current knowledge of the cellular and molecular mechanisms by which PMOS disrupts endometrial function. We discuss how hyperandrogenism, insulin resistance, obesity, and chronic inflammation, both independently and collectively, impair endometrial receptivity by altering androgen receptor (AR) signaling, glucose metabolism, extracellular matrix (ECM) remodeling, immune homeostasis, cell-cell junctions, adhesion molecules, and key regulators of decidualization. We also highlight recent advances in transcriptomic and single-cell sequencing studies that have revealed cell type-specific alterations and molecular heterogeneity within the PMOS endometrium. Despite substantial progress, the mechanisms linking endocrine and metabolic abnormalities to impaired endometrial function remain incompletely understood. A better understanding of PMOS-associated endometrial dysfunction will facilitate the identification of novel therapeutic targets and improve embryo implantation success, pregnancy outcomes, and reproductive health in women with PMOS.